[Comparative study of the effects of regular or on-demand salbutamol inhalation in the treatment of asthma]
- PMID: 3532315
[Comparative study of the effects of regular or on-demand salbutamol inhalation in the treatment of asthma]
Abstract
52 asthmatic patients aged 18 to 70 years took part in a double-blind crossover trial comparing the effects of regular treatment of asthma with inhaled salbutamol (400 micrograms qds) versus irregular treatment (400 micrograms prn), each prescribed for 4 weeks. There were no differences between the two schedules regarding intensity of clinical symptoms, morning and evening values of peak expiratory flow rates and spirometric measurements. The mean daily consumption of salbutamol was higher in the period of regular treatment (2148 +/- 548 micrograms) than in the period of free treatment (800 +/- 700 micrograms). Patients expressed an obvious preference for the period of regular treatment (26 vs 13). Salbutamol given prn or on a regular qds regimen was shown to be equally effective and safe in controlling the signs and symptoms of asthma. No tolerance or drug abuse was observed. In view of the patients' preference for regular treatment, this schedule is a safe alternative in cases where low-dose symptomatic treatment given prn fails to alleviate symptoms.
Similar articles
-
Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).Respir Med. 2000 Jun;94(6):612-21. doi: 10.1053/rmed.2000.0806. Respir Med. 2000. PMID: 10921768 Clinical Trial.
-
[Salmeterol improves the control of disease in patients with moderate asthma. A comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily].Ugeskr Laeger. 1996 Jul 1;158(27):3940-3. Ugeskr Laeger. 1996. PMID: 8701511 Clinical Trial. Danish.
-
[Salmeterol improves control in asthmatic patients treated in general practice. A comparative study of salmeterol (Serevent) and salbutamol (Ventoline) in patients with mild to moderate asthma].Ugeskr Laeger. 1995 Jan 2;157(1):36-40. Ugeskr Laeger. 1995. PMID: 7839545 Clinical Trial. Danish.
-
Salmeterol xinafoate in children on high dose inhaled steroids.Ann Allergy Asthma Immunol. 1995 Nov;75(5):423-8. Ann Allergy Asthma Immunol. 1995. PMID: 7583864 Clinical Trial.
-
Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.Respir Med. 2000 Aug;94(8):767-71. doi: 10.1053/rmed.2000.0820. Respir Med. 2000. PMID: 10955752 Clinical Trial.
Cited by
-
The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.Drug Saf. 1994 Oct;11(4):259-83. doi: 10.2165/00002018-199411040-00005. Drug Saf. 1994. PMID: 7848546 Review.
-
Inhaled short acting beta2-agonist use in asthma: regular vs as needed treatment.Cochrane Database Syst Rev. 2000;2003(4):CD001285. doi: 10.1002/14651858.CD001285. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2003;(2):CD001285. doi: 10.1002/14651858.CD001285 PMID: 11034709 Free PMC article. Updated. Review.